1-2 of 2
Carlos Richard Espiga
Close
Sort by
Journal Articles

Relapse Risk Score after Allogeneic Stem Cell Transplantation for MDS Patients. an EBMT Study from the MDS Subcommittee of Chronic Malignancies Working Party (CMWP)

Nicolaus Kröger, MD, Hein Putter, Prof. Dr, Liesbeth De Wreede, Anja van Biezen, Dimitris Ziagkos, Liisa Volin, MD PhD, Johan Maertens, MD PhD, Jürgen Finke, Per T. Ljungman, MD PhD, Nigel H. Russell, V, MD, Ibrahim Yakoub-Agha, Michel Schaap, MD PhD, Charles Craddock, MD PhD, Ghulam J Mufti, MD, Patrice Chevallier, MD PhD, Jakob R Passweg, MD, Noel Milpied, MD PhD, Didier Blaise, MD PhD, Jean-Henri Bourhis, MD PhD, Tobias Gedde-Dahl, Carlos Richard Espiga, MD, Jan J. Cornelissen, MD PhD, Gudrun Göhring, MD, Johannes Schetelig, MD MSc, Theo de Witte, MD, Marie Robin, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4701.
https://doi.org/10.1182/blood.V128.22.4701.4701
Published: 2016
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome (MDS) Patients at Lower Risk According to International Prognostic Scoring System (IPSS) : A Retrospective Study on Behalf of the Cmwp of the EBMT

Marie Robin, MD PhD, Porcher Raphael, Anja van Biezen, Liisa Volin, MD, Ghulam J. Mufti, DM, FRCP, FRCPath, Charles Craddock, MDPhD, Jurgen Finke, MD, Carlos Richard Espiga, Jakob Passweg, MD, Andrew Peniket, Johan Maertens, MD, Gulsan Sucak, MD, Tobias Gedde-Dahl, Antonin Vitek, Arnon Nagler, MD, Didier Blaise, MD, Dietrich Beelen, MD, Natacha Maillard, MD, Rainer Schwerdtfeger, MD, Simona Iacobelli, PhD, Theo de Witte, MD, Nicolaus Kroeger, MD
Journal: Blood
Blood (2014) 124 (21): 2530.
https://doi.org/10.1182/blood.V124.21.2530.2530
Published: 2014